[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604312":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":23,"centralContacts":29,"locations":10,"responsibleParty":36,"collaborators":10,"id":38,"slug":10,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":10,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":49,"studyType":50,"phases":10,"briefSummary":51,"conditions":52,"keywords":56,"overallStatus":60,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":10},{"fullName":5,"class":6},"Neurolutions, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Adult stroke patients with upper extremity hemiparesis.",null,"Chronic Stroke Patients (≥ 6 months post-stroke) age 18 or older undergoing stroke rehabilitation with use of the IpsiHand® System.",[13],"Device: IpsiHand",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","IpsiHand","IpsiHand is a therapeutic device that uses a brain-computer interface system which detects neural signals associated with motor intent and translates them into assisted hand movements in individuals with upper extremity impairment following a stroke.",[9],[21,22],"IpsiHand Therapy","BCI Therapy",[24,27],{"name":25,"affiliation":5,"role":26},"Seth Wilk, PhD","PRINCIPAL_INVESTIGATOR",{"name":28,"affiliation":10,"role":26},"Lee Fleisher, MD",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Lauren Souders, MOT, OTR\u002FL, CBIS, CSRS","CONTACT","213-286-3323","innovation@kandu.com",{"name":25,"role":32,"phone":33,"phoneExt":10,"email":34},{"type":37,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100604312",false,"NCT07147881","Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors","Inclusion Criteria:\n\n1. Adult age 18-85 years.\n2. Diagnosis of stroke six or more months prior with upper extremity weakness.\n3. Has received an IpsiHand® system as a commercial customer for stroke rehabilitation.\n\nExclusion Criteria:\n\n1. Severe cognitive impairment that would impede utilization of IpsiHand®\n2. Any contraindications to IpsiHand® device use\n3. Inability to comprehend English","ALL","18 Years","85 Years",{"count":47,"type":48},100,"ESTIMATED","2 Years","OBSERVATIONAL","This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.",[53,54,55],"Stroke","Hemiparesis After Stroke","Brain Computer Interface",[57,17,53,58,59],"Neurolutions","Hemiparesis after stroke","BCI","NOT_YET_RECRUITING","2025-08-22",{"date":63,"type":64},"2025-08-29","ACTUAL",{"date":66,"type":48},"2025-09-01",{"date":68,"type":48},"2028-01-01",{"name":5,"class":6}]